PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Change in RTA
We have been informed by Karvy Fintech Private Limited, our Registrar and Share Transfer Agent ('RTA'), that their name has changed to KFin Technologies Private Limited effective December 5, 2019. Accordingly, we request you to kindly update the name of our RTA as KFin Technologies Private Limited in your records. Please take the above on record.
Pfizer's brand strategy is paying off, but the valuations are pricey
The recent run-up in its stock price has raised the 12-month trailing earnings to around 39 times earningspershare.Some of its specialty brands helped Pfizer command better pricing, particularly in vaccines, vitamins and cardiovascular segments PFIZER LTD. - 500680 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2019. The said disclosure is also available on the website of the Company i.e., www.pfizerindia.com. Please take the above on record. Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') Pfizer raises 2019 forecast as sales of cancer drug, heart medicine surge
Excluding special items, Pfizer earned 75 cents per share, topping analysts' average estimate by 13 cents Pfizer Q2 net up 61% to Rs 154.25 cr
Pharma firm Pfizer Ltd on Saturday reported a 61.01 per cent rise in net profit to Rs 154.25 crore for the July-September quarter compared to that of Pfizer Ltd - 500680 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2019.
Unaudited Financial Results for the quarter and half year ended September 30, 2019. PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificates and issue of duplicate share certificates